Percutaneous absorption promoter, a tape plaster and a method of promoting percutaneous absorption
A percutaneous absorption promoter comprises a derivative of amino acid in which the amino group has or does not have an acyl substituent or a hydrocarbon substituent, the carboxylic group has a hydrocarbon substituent and the part between the amino group and the carboxylic group has a specified structure. A tape plaster comprises the percutaneous absorption promoter described above. The method utilizes the the percutaneous absorption promoter described above. The percutaneous promoter of the invention has excellent ability of promoting the percutaneous absorption of pharmacologically active substances and excellent safety simultaneously, capable of delivering the desired pharmacologically active substances rapidly to the location of treatment or to all parts of the body through the circulating system and effective for curing various kinds of disease. The tape plaster comprising it and the method of promoting percutaneous absorption by utilizing it have the same advantages.
Latest Lintec Corporation Patents:
- WIRING SHEET FOR THREE-DIMENSIONAL MOLDING
- ADHESIVE SHEET AND METHOD FOR MANUFACTURING STRUCTURE
- ACTINIC RAY-CROSSLINKABLE ADHESIVE AGENT COMPOSITION, CROSS-LINKED ADHESIVE AGENT, ADHESIVE SHEET, AND METHODS FOR MANUFACTURING SAME
- RELEASE LINER AND ADHESIVE SHEET
- Thermoelectric conversion body, thermoelectric conversion module, and method for manufacturing thermoelectric conversion body
Claims
1. A percutaneous absorption promoter composition which comprises (a) a pharmaceutically active substance and (b) a derivative of amino acid having the formula:
2. A percutaneous absorption promoter as claimed in claim 1 wherein R.sup.1 is a saturated or unsaturated aliphatic acyl group having 1 to 20 carbon atoms and R.sup.2 is a saturated or unsaturated aliphatic hydrocarbon group having 1 to 4 carbon atoms.
3. A percutaneous absorption promoter as claimed in claim 1 wherein R.sup.1 is a saturated or unsaturated linear aliphatic acyl group having 2 to 16 carbon atoms and R.sup.2 is a saturated or unsaturated aliphatic hydrocarbon group having 1 to 4 carbon atoms.
4. A percutaneous absorption promoter as claimed in claim 1 wherein R.sup.4 is a hydrogen atom.
5. A tape plaster comprising a percutaneous absorption promoter composition as claimed in claim 1 said tape plaster comprising an adhesive material containing the amino acid derivative and at least one pharmacologically active substance coated on a tape substrate.
6. A tape plaster as claimed in claim 5 wherein R.sup.1 is a saturated or unsaturated aliphatic acyl group having 1 to 20 carbon atoms and R.sup.2 is a saturated or unsaturated aliphatic hydrocarbon group having 1 to 4 carbon atoms.
7. A tape plaster as claimed in claim 5 wherein R.sup.1 is a saturated or unsaturated linear aliphatic acyl group having 2 to 16 carbon atoms and R.sup.2 is a saturated or unsaturated aliphatic hydrocarbon group having 1 to 4 carbon atoms.
8. A tape plaster as claimed in claim 5 wherein R.sup.4 is a hydrogen atom.
9. A tape plaster as claimed in claim 5 wherein the pharmacologically active substance is selected from the group consisting of indomethacin, ketoprofen, predonisolone and pindolol.
10. A tape plaster as claimed in claim 5 wherein the pharmacologically active substance is selected from the group consisting of indomethacin, predonisolone and pindolol.
11. A method of promoting percutaneous absorption which comprises promoting percutaneous absorption of a pharmacologically active substance by applying a percutaneous absorption promoter in combination with the pharmacologically active substance to a patient topically and percutaneously, the percutaneous absorption promoter comprising a derivative of amino acid having the formula:
13. A method of promoting percutaneous absorption as claimed in claim 11 wherein R.sup.1 is a saturated or unsaturated linear aliphatic acyl group having 2 to 16 carbon atoms and R.sup.2 is a saturated or unsaturated aliphatic hydrocarbon group having 1 to 4 carbon atoms.
14. A method of promoting percutaneous absorption as claimed in claim 11 wherein R.sup.4 is a hydrogen atom.
15. A method of promoting percutaneous absorption as claimed in claim 11 wherein the pharmacologically active substance is selected from the group consisting of indomethacin, ketoprofen, predonisolone and pindolol.
16. A method of promoting percutaneous absorption as claimed in claim 11 wherein the pharmacologically active substance is selected from the group consisting of indomethacin, predonisolone and pindolol.
17. A percutaneous absorption promoter composition as claimed in claim 1 which further comprises an adhesive effective to cause the composition to adhere to skin to which it is applied.
18. The percutaneous absorption promoter of claim 1, where R.sup.3 is ##STR4##
19. The tape plaster of claim 5, wherein R.sup.3 is ##STR5##
20. The method of promoting percutaneous absorption of claim 11, wherein R.sup.3 is ##STR6##
21. A percutaneous absorption promoter composition which comprises (a) a pharmaceutically active substance and (b) a derivative of an amino acid having the formula: ##STR7## wherein R.sup.1 is.Iadd.a hydrogen atom,.Iaddend.an acyl group having 1 to 20 carbon atoms,.Iadd.or a hydrocarbon group having 1 to 20 carbon atoms,.Iaddend.and R.sup.2 is a hydrogen atom or a hydrocarbon group having 1 to 20 carbon atoms.
22. A method of promoting percutaneous absorption which comprises promoting percutaneous absorption of a pharmaceutically active substance by applying a percutaneous absorption promoter composition of claim 21 to a patient topically and percutaneously.
| 3969087 | July 13, 1976 | Saito et al. |
| 4732892 | March 22, 1988 | Sarpotdar et al. |
| 4789667 | December 6, 1988 | Makino |
| 4808414 | February 28, 1989 | Peck |
| 4963556 | October 16, 1990 | Alexander |
| 4980378 | December 25, 1990 | Wong et al. |
| 5059628 | October 22, 1991 | Tsuda |
| 5082866 | January 21, 1992 | Wong |
| 2281162 | March 1976 | FRX |
- Patent Abstracts of Japan, vol. 011, No. 063, Feb. 26, 1987. Patent Abstracts of Japan, vol. 9, No. 324, Dec. 19, 1985.
Type: Grant
Filed: May 8, 1997
Date of Patent: Mar 9, 1999
Assignee: Lintec Corporation (Tokyo)
Inventors: Eiji Suzuki (Urawa), Hideaki Okabe (Urawa), Takanori Saito (Misato)
Primary Examiner: Thurman K. Page
Assistant Examiner: D. Gabrielle Brouillette
Law Firm: Millen, White, Zelano, & Branigan, P.C.
Application Number: 8/854,136
International Classification: A61F 1300;
